Haibo Xiao
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 9
- Oncology top 10%
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 9
- Ubiquitin and proteasome pathways 4
-
- Pectus Deformity Diagnosis and Treatment 7
- Reconstructive Surgery and Microvascular Techniques 4
-
- Traumatic Ocular and Foreign Body Injuries 3
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Haibo Xiao
53 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 425
- Oncology 364
- Molecular Biology 685
- Immunology 209
- Pulmonary and Respiratory Medicine 174
Countries citing papers authored by Haibo Xiao
This map shows the geographic impact of Haibo Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Xiao more than expected).
Fields of papers citing papers by Haibo Xiao
This network shows the impact of papers produced by Haibo Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Xiao. The network helps show where Haibo Xiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haibo Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 35 | |
| 5 | 2022 | 27 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 4 | |
| 9 | Methylcrotonoyl-CoA Carboxylase 2 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Prostate Cancer Cells Through Regulating GLUD1-P38 MAPK Signaling Pathway | 2020 | 2 |
| 10 | 2016 | 5 | |
| 11 | 2015 | 31 | |
| 12 | 2013 | 7 | |
| 13 | 2013 | 17 | |
| 14 | 2013 | 17 | |
| 15 | 2013 | 58 | |
| 16 | 2012 | 15 | |
| 17 | Preparation and properties of Mn_(1.5-0.5x)Co_(1.5-0.5x)Cu_xO_4 spinel powders and coatings | 2012 | 1 |
| 18 | 2010 | 1 | |
| 19 | 2008 | 60 | |
| 20 | Analysis of finished main cable shape of self-anchored suspension bridges | 2004 | 2 |
About Haibo Xiao
Haibo Xiao is a scholar working on Cancer Research, General Engineering and Geriatrics and Gerontology, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (9 papers), RNA modifications and cancer (9 papers), Circular RNAs in diseases (9 papers), Pectus Deformity Diagnosis and Treatment (7 papers), Ubiquitin and proteasome pathways (4 papers), Reconstructive Surgery and Microvascular Techniques (4 papers) and Traumatic Ocular and Foreign Body Injuries (3 papers). The work is most often cited by research in Cancer Research (425 citations), Oncology (364 citations) and Molecular Biology (685 citations). Haibo Xiao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Fengqing Hu, Xiao Xie, Ju Mei, Fangbao Ding, Mingsong Wang, Rui Hu, Zheyi Chen, Yingxia Zheng, Shiyu Chen and Bingqian Zhou. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.